Aptamer Group (APTA) Competitors GBX 0.28 +0.03 (+10.80%) As of 12:28 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock APTA vs. OPTI, AREC, POLB, RLM, NSCI, IMM, SNG, BVX, OBD, and IXIShould you be buying Aptamer Group stock or one of its competitors? The main competitors of Aptamer Group include OptiBiotix Health (OPTI), Arecor Therapeutics (AREC), Poolbeg Pharma (POLB), Realm Therapeutics (RLM), NetScientific (NSCI), ImmuPharma (IMM), Synairgen (SNG), BiVictriX Therapeutics (BVX), Oxford BioDynamics (OBD), and IXICO (IXI). These companies are all part of the "biotechnology" industry. Aptamer Group vs. OptiBiotix Health Arecor Therapeutics Poolbeg Pharma Realm Therapeutics NetScientific ImmuPharma Synairgen BiVictriX Therapeutics Oxford BioDynamics IXICO Aptamer Group (LON:APTA) and OptiBiotix Health (LON:OPTI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Do institutionals and insiders believe in APTA or OPTI? 11.7% of Aptamer Group shares are owned by institutional investors. Comparatively, 4.9% of OptiBiotix Health shares are owned by institutional investors. 13.2% of Aptamer Group shares are owned by insiders. Comparatively, 12.0% of OptiBiotix Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor APTA or OPTI? OptiBiotix Health received 145 more outperform votes than Aptamer Group when rated by MarketBeat users. CompanyUnderperformOutperformAptamer GroupN/AN/AOptiBiotix HealthOutperform Votes14559.18% Underperform Votes10040.82% Does the media favor APTA or OPTI? In the previous week, Aptamer Group's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score. Company Overall Sentiment Aptamer Group Neutral OptiBiotix Health Neutral Which has more volatility & risk, APTA or OPTI? Aptamer Group has a beta of -0.52, meaning that its stock price is 152% less volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.71, meaning that its stock price is 71% more volatile than the S&P 500. Is APTA or OPTI more profitable? Aptamer Group has a net margin of -343.95% compared to OptiBiotix Health's net margin of -524.43%. OptiBiotix Health's return on equity of -36.76% beat Aptamer Group's return on equity.Company Net Margins Return on Equity Return on Assets Aptamer Group-343.95% -205.63% -44.96% OptiBiotix Health -524.43%-36.76%-13.93% Which has preferable valuation and earnings, APTA or OPTI? OptiBiotix Health has lower revenue, but higher earnings than Aptamer Group. OptiBiotix Health is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptamer Group£4.12M1.34-£14.17M-£0.71-0.39OptiBiotix Health£590.01K30.71-£3.09M-£3.16-5.86 SummaryAptamer Group and OptiBiotix Health tied by winning 6 of the 12 factors compared between the two stocks. Get Aptamer Group News Delivered to You Automatically Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APTA vs. The Competition Export to ExcelMetricAptamer GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£5.51M£120.63M£5.42B£2.52BDividend YieldN/A3.69%5.44%4.96%P/E Ratio-0.393.0022.18131.73Price / Sales1.344,182.26397.31238,268.04Price / CashN/A13.0238.2028.02Price / Book1.3034.586.834.47Net Income-£14.17M-£90.45M£3.20B£5.81B7 Day Performance6.54%1.71%5.79%1.56%1 Month Performance-3.15%-3.74%-5.53%5.40%1 Year Performance-68.31%90.77%16.85%101.20% Aptamer Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTAAptamer GroupN/AGBX 0.28+10.8%N/A-65.5%£5.51M£4.12M-0.3937High Trading VolumeOPTIOptiBiotix HealthN/AGBX 19.33+0.4%N/A+8.6%£18.93M£590,009.23-6.121ARECArecor TherapeuticsN/AGBX 38.28+0.7%N/A-71.2%£14.45M£6.04M-1.3510Earnings ReportNews CoveragePositive NewsHigh Trading VolumePOLBPoolbeg PharmaN/AGBX 2.62-3.0%N/A-74.0%£13.47MN/A0.0012Gap DownRLMRealm TherapeuticsN/AN/AN/AN/A£13.41M£501,919.00-0.66N/ANSCINetScientificN/AN/AN/AN/A£12.81M£1.45M-486.3626IMMImmuPharmaN/AGBX 2.45-3.9%N/A+23.8%£10.42M£-71,310.29-4.2413Gap DownSNGSynairgenN/AGBX 0.93-2.6%N/A-86.5%£9.04MN/A-0.5634Gap DownBVXBiVictriX TherapeuticsN/AN/AN/AN/A£8.25MN/A-250.0017Gap UpHigh Trading VolumeOBDOxford BioDynamicsN/AGBX 0.43-4.0%N/A-94.7%£8.15M£5.75M-0.0845Gap UpIXIIXICON/AGBX 8.52-5.3%N/A+0.2%£7.90M£11.50M-2.2189Gap Down Related Companies and Tools Related Companies OptiBiotix Health Alternatives Arecor Therapeutics Alternatives Poolbeg Pharma Alternatives Realm Therapeutics Alternatives NetScientific Alternatives ImmuPharma Alternatives Synairgen Alternatives BiVictriX Therapeutics Alternatives Oxford BioDynamics Alternatives IXICO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:APTA) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptamer Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptamer Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APTA Stock Free APTA Stock Alerts